Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Expert Opinion on Biological Therapy|April 30, 2013
Omalizumab for treatment of allergic rhinitisPriyanka Vashisht, Thomas Casale
Drug Discovery Today|February 7, 2012
Monoclonal antibodies for chronic refractory asthma and pipeline developmentsRiccardo Polosa, Thomas Casale
Biology|August 28, 2024
Molecular Pathways and Potential Therapeutic Targets of Refractory AsthmaLeah Ishmael, Thomas Casale, Juan Carlos Cardet
The Journal of Allergy and Clinical Immunology|January 18, 2003
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthmaJonathan Corren, Thomas Casale, Yamo Deniz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 11, 2020
Allergic Endotypes and Phenotypes of AsthmaNicole Akar-Ghibril, Thomas Casale, Adnan Custovic, et al.
Chest|May 11, 2006
Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthmaEric Bateman, Jill Karpel, Thomas Casale, et al.
The World Allergy Organization Journal|September 1, 2017
Severe asthma and quality of lifeElham Hossny, Luis Caraballo, Thomas Casale, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 25, 2016
Updating Allergy and/or Hypersensitivity Diagnostic Procedures in the WHO ICD-11 RevisionLuciana Kase Tanno, Moises A Calderon, James Li, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2005
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammationStephen Holgate, Thomas Casale, Sally Wenzel, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthmaMarc Massanari, Harold Nelson, Thomas Casale, et al.
Pageof 7